z-logo
open-access-imgOpen Access
Continuous renal replacement therapy versus furosemide for management of kidney impairment in heart transplant recipients with volume overload
Author(s) -
Seyed Mohsen Mirhosseini,
Mohammad Fakhri,
Shadi Asadollahi,
Zargham Hossein Ahmadi,
Farin Rashid Farokhi,
Mohammad Reza Boloursaz,
Mohammad Reza Masjedi
Publication year - 2012
Publication title -
interactive cardiovascular and thoracic surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.546
H-Index - 56
eISSN - 1569-9293
pISSN - 1569-9285
DOI - 10.1093/icvts/ivs492
Subject(s) - medicine , furosemide , renal function , renal replacement therapy , urology , transplantation , kidney disease , volume overload , kidney transplantation , kidney , cardiology , heart failure , surgery
It is unknown whether continuous renal replacement therapy or furosemide therapy is superior in heart transplant recipients who are in postoperative kidney insufficiency and volume overload. This prospective non-randomized, controlled trial investigated the efficacy of the two methods after transplantation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom